Cedric Francois - Concepedia

Author

Cedric Francois

Also Known As

C Francois, C François, C. Francois, C. François, Cedric Francois, Cedric G Francois, Cedric G. Francois, Célia François, Francois, Cedric, Ron Cohen

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Louisville Apellis Pharmaceuticals (United States)Christine M. Kleinert Institute Prince of Wales Hospital Chinese University of Hong Kong

About

Cedric Francois is an author at University of Louisville specializing in medicine, autoimmunity, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	686
2	Health Sciences	1	1	13
3	Nursing	1	1	16
4	Public Health	1	1	16
5	Allergy	1	1	64

Cedric Francois

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration David Liao, F Grossi, Delphine El Mehdi, Ophthalmology	2019	491
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz, The Lancet Ocular DiseaseOphthalmologyAge-related DiseasesGeographic AtrophyAge-related Macular Degeneration	2023	372
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Peter Hillmen, Jeff Szer, Ilene C. Weitz, New England Journal of Medicine	2021	356
Hand transplantation: Comparisons and observations of the first four clinical cases Cedric Francois, Warren C. Breidenbach, Claudio Maldonado, Microsurgery	2000	178
On the Ethics of Facial Transplantation Research Osborne P. Wiggins, John H. Barker, Serge A. Martinez, The American Journal of Bioethics Transplantation SurgeryMedical EthicsTransplantationCosmetic SurgeryTransplantation Medicine	2004	123
<scp>C3</scp> inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab Carlos de Castro, F Grossi, Ilene C. Weitz, American Journal of Hematology	2020	97
Investigation of Risk Acceptance in Facial Transplantation John H. Barker, Allen Furr, Michael Cunningham, Plastic & Reconstructive Surgery	2006	68
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial Régis Peffault de Latour, Jeff Szer, Ilene C. Weitz, The Lancet Haematology Chronic Kidney DiseaseHematologyPegcetacoplan Versus EculizumabMedicineParoxysmal Nocturnal Haemoglobinuria	2022	65
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood Corinne J. Smith, Nikki L. Ross, Ali Kamal, Frontiers in Immunology Adaptive Immune SystemCellular ImmunologyViral PathogenesisImmunologyImmune Regulation	2022	64
Risk acceptance in composite-tissue allotransplantation reconstructive procedures Pascal C. R. Brouha, Deepak K. Naidu, Michael Cunningham, Microsurgery	2006	51

Page 1